Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Keil

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Journal of Immunotoxicology|January 5, 2012
Immune function in female B(6)C(3)F(1) mice is modulated by DE-71, a commercial polybrominated diphenyl ether mixturePatricia A Fair, Hui-Chen Stavros, Meagan A M Mollenhauer, et al.
BMC Cancer|September 13, 2021
Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in GermanyD Dimitrova, B Naghavi, R Richter, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1983
Childhood familial and racial differences in physiologic and biochemical factors related to hypertensionA R Hohn, D A Riopel, J E Keil, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 17, 2008
Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS)Margie M Peden-Adams, Joyce E Stuckey, Kristen M Gaworecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR)J Sehouli, R Chekerov, A Reinthaller, et al.
Experimental and Clinical Endocrinology|February 1, 1983
Long term toxicological studies on the progestin STS 557H Hoffmann, H G Hillesheim, J Güttner, et al.
European Journal of Epidemiology|September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, J Danesh, S Erqou, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Journal of Immunotoxicology|January 5, 2012
Immune function in female B(6)C(3)F(1) mice is modulated by DE-71, a commercial polybrominated diphenyl ether mixturePatricia A Fair, Hui-Chen Stavros, Meagan A M Mollenhauer, et al.
BMC Cancer|September 13, 2021
Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in GermanyD Dimitrova, B Naghavi, R Richter, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1983
Childhood familial and racial differences in physiologic and biochemical factors related to hypertensionA R Hohn, D A Riopel, J E Keil, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 17, 2008
Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS)Margie M Peden-Adams, Joyce E Stuckey, Kristen M Gaworecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR)J Sehouli, R Chekerov, A Reinthaller, et al.
Experimental and Clinical Endocrinology|February 1, 1983
Long term toxicological studies on the progestin STS 557H Hoffmann, H G Hillesheim, J Güttner, et al.
European Journal of Epidemiology|September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, J Danesh, S Erqou, et al.
Pageof 17